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Generalized anxiety disorder (GAD) was initially introduced in the revised third edition of the Diagnostic 
and Statistical Manual of Mental Disorders (DSM-III-R) as a diagnosis to help characterize chronic and 
excessive worry. Today, GAD is one of the most common anxiety disorders in the general population and 
practice. Although GAD is an increasingly popular area of research, it remains in a premature state. This 
is evident by a lack of empirically supported assessment measures, intervention strategies, and treatment 
options. The purpose of this paper is to briefly review current empirically based assessment and treatment 
interventions for GAD commonly used in child, adolescent, and adult populations.
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Worry is common in everyday functioning 
(Borkovec & Inz, 1990). However, when one’s 
level of worry progresses to an extent that it 
seems uncontrollable and begins interfering 
with normative functioning, intervention may be 
required. Generalized Anxiety Disorder (GAD), 
introduced in the third edition of Diagnostic and 
Statistical Manual of Mental Disorders (DSM-III-R), 
is a chronic and pervasive disorder characterizing 
unremittent and excessive worry (American 
Psychiatric Association, 1987; Roemer & Orsillo, 
2002). The DSM-V identifies GAD as excessive 
anxiety and uncontrollable worry across a variety 
of domains that lasts at least six months, causing 
clinically significant distress and including at least 
three of the following symptoms: muscle tension, 
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restlessness, difficulty concentrating, fatigue, 
irritability, and/or sleep disturbance (American 
Psychiatric Association, 2013).
GAD is among the most common anxiety disorders 
encountered in the general population and 
practice (Spitzer, Kroenke, Williams, & Löwe, 2006; 
Statistics Canada, 2015). The lifetime prevalence 
rate of GAD in the general population is ~5% (~3.6% 
and ~6.6% for males and females, respectively; 
Waddell, Shepherd, Schwartz, & Barican, 2014), 
and between 2.8% and 8.5% in medical practice 
(Spitzer et al., 2006). Further, ~3% of the general 
population in Canada has a diagnosis of GAD 
(Statistics Canada, 2015). Of this 3%, ~0.7% are 
children and adolescents (C/As) between 4-17 
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years (Waddell et al., 2014). However, these 
estimates are conservative; far more individuals 
likely suffer from the associated symptoms, yet 
lack a diagnosis (Waddell et al., 2014). 
With C/A populations, the nature of worry in 
this period of development makes it difficult to 
differentiate normal levels from excessive (Cheng 
& Myers, 2011). Typical worry content in C/As with 
GAD pertains to the health of self and of significant 
others, school performance, appearance, and 
familial conflict (Cheng & Myers, 2011). A unique 
assessment factor in the DSM-V for diagnosing 
GAD in C/A populations is the requirement of only 
one GAD-associated symptom, as compared to 
three for adult populations (Cheng & Myers, 2011). 
This unique factor represents findings that mental 
disorders are the greatest risk to C/As health in 
Canada (Waddell et al., 2014). Yet, many C/As 
facing mental health issues, such as GAD, are 
not receiving the support needed (Waddell et al., 
2014). In Canada, only 1-in-5 C/As requiring mental 
health services are receiving them (Canadian 
Mental Health Association, 2016). The lack of 
available support is having detrimental effects on 
C/As, such as increased rates of suicide (Canadian 
Mental Health Association, 2016). It is critical that 
C/As with symptoms of GAD receive immediate 
and effective intervention, with the goal being to 
reduce overall impairment and guide them toward 
their highest potential (Waddell et al., 2014).
While C/As with GAD struggle to acquire support in 
terms of treatment, adult populations experience 
their own challenges. GAD is commonly 
conceptualized as reflecting the central process 
of all emotional disorders (e.g., Barlow, 2004). 
Consequentially, much of GAD research within 
this population is riddled with varying conceptual 
definitions and diagnostic criteria (Wittchen & 
Hoyer, 2001). To account for this, research has 
recently focused on examining the effectiveness 
of existing GAD treatment models and how they 
may be altered and/or combined to produce novel 
interventions (Huppert & Sanderson, 2010). While 
this approach is promising, a greater understanding 
of GAD etiological factors may help researchers 
and clinicians form more effective prevention and 
treatment methods for adults.
There are currently five major models of GAD 
(Behar, DiMarco, Hekler, Mohlman, & Staples, 
2009):
• The Avoidance Model of Worry and 
GAD (AMW; Mowrer, 1947), arguing 
that word-based worry inhibits mental 
imagery in an attempt to manage anxiety. 
• The Intolerance of Uncertainty Model (IUM; 
Dugas, Gagnon, Ladouceur, & Freeston, 
1998), emphasizing that the stressful and 
overwhelming nature of uncertain situations. 
• The Acceptance Based Model (ABM; Roemer & 
Orsillo, 2002), proposing that individuals with 
GAD negatively react to internal experiences, 
and use worry to avoid these experiences. 
• The Emotion Dysregulation Model 
(EDM; Mennin, et al., 2002), focusing 
on issues with emotion regulation. 
• The Metacognitive Model of Worry (MCM; 
Wells, 1995), suggesting individuals with 
GAD have negative beliefs about their worry. 
Of these five models, the AMW is the most commonly 
discussed in C/A populations (Borkovec, Alcaine, 
& Behar, 2004). According to the AMW, worry is 
primarily word-based (i.e., experiencing worry 
via thoughts) as opposed to imagery-based (i.e., 
experiencing worry via mental images; Borkovec et 
al., 2004). Anxiety results from imagining a feared 
potential future event – the purpose of worrying is 
to inhibit this mental imagery to control the anxiety. 
However, this strategy is often ineffective. Despite 
this, the AMW proposes that C/As with GAD still 
see worry as a coping mechanism, as it is at times 
negatively reinforced (Borkovec & Roemer, 1995). It 
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is hypothesized that early exposure to significant 
stress and trauma increases the likelihood of a 
C/A developing GAD (Borkovec et al., 2004). These 
C/As lack opportunities to build effective coping 
mechanisms and thus struggle with uncertain 
events, leading to excessive worry and anxiety. 
Furthermore, the AMW argues that when a child 
develops an insecure attachment style to parental 
figures, this encourages viewing the world as a 
generally dangerous place, in turn increasing the 
chances of developing GAD (Borkovec et al., 2004; 
Cassidy, Lichtenstein-Phelps, Sibrava, Thomas, & 
Borkovec, 2009).
In adult populations, Newman and colleagues 
(2013) identify environmental, attachment and 
parenting style, and temperament as risk factors 
for GAD development. Environmental factors 
include unexpected life factors, maltreatment, 
and loss, which can contribute to a questioning 
of values, beliefs, and overall outlook on life. 
Attachment and parenting style, as previously 
mentioned, affect emotion regulation, at which 
patterns of insecure attachment increase the risk 
of developing GAD. Additionally, negative parenting 
behaviors, such as parental rejection and harsh 
discipline, are associated with offspring worry and 
adult-onset GAD. The last risk factor identified 
(Newman et al., 2013), temperament, describes 
individual dispositions in biological, behavioral, 
and emotional responsiveness to environmental 
stimuli. The tendency to be easily aroused in mid-
childhood, for instance, is associated with the 
development and maintenance of GAD symptoms. 
Although GAD is an increasingly popular area of 
research with several models available to explain 
its nature, the area is nevertheless in a premature 
state (Mennin, Heimberg, Turk, & Fresco, 2002). 
The objective of this paper is to provide a brief 
review of current empirically-based assessment 
measures and treatment interventions for 
GAD across C/A and adult populations. While 
other reviews focus on C/A (e.g., Wagner, 2001) 
and adult (e.g., Locke, Kirst, & Shultz, 2015) 
populations individually, to the authors’ knowledge, 
few include all age ranges. Furthermore, this article 
intends to provide a foundation for understanding 
current conceptualizations of GAD among an 
interdisciplinary audience.
Assessment
Children and Adolescents
GAD in C/As is typically chronic and has greater 
comorbidity with other disorders compared to 
adult-onset, making early detection essential 
(Cheng & Myers, 2011). It is recommended that 
assessment includes a clinical interview with the 
child and guardian independently, the completion of 
objective ratings scales by several informants, and 
alternative explanations for symptoms be ruled out 
(Cheng & Myers, 2011). Additionally, assessment 
of risk to clients’ safety, developmental levels, 
triggers, and environmental factors should be 
considered (Cheng & Myers, 2011). While several 
self-report scales are available to assist clinicians 
in differentiating typical levels of daily worry from 
that which is abnormal, many of these tools are 
specific to adult populations (Behar et al., 2009). 
A direct implication of insufficient research 
regarding GAD in C/As is a lack of assessment 
measures. Of the limited assessment measures 
available, the authors suggest that few appear to 
be popular among clinicians. There are measures 
for C/As independently, and those that can be 
administered to both populations. The following 
GAD assessment tools for C/A populations are 
highlighted in the present paper: the Anxiety 
Disorders Interview Schedule for Children and 
Parents (ADIS-C/P; Silverman & Nelles, 1988); the 
Youth Anxiety Measure for DSM-5 (YAM-5; Muris et 
al., 2017); and the Severity Measure for Generalized 
Anxiety Disorder (Craske et al., 2013). 
The ADIS-C/P
The ADIS-C/P is a semi-structured interview 
intended for child populations in addressing 
various anxiety disorders, including: generalized 
Spectrum  |  InterdIScIplInary undergraduate reSearch 4
doi: 
PUBLISHED:Published:
10.29173/spectrum24
October, 2018
anxiety disorder, separation anxiety disorder, 
panic disorder, specific phobias, social phobia, 
and obsessive-compulsive disorder (Silverman 
& Nelles, 1988). Administered by clinicians, it is 
completed by the child (ADIS-C) and guardian 
(ADIS-P). The ADIS-C/P consists of measuring 
the presence and severity of anxiety and related 
symptoms, investigating both level of distress and 
impairment of normative functioning. 
Following the interviews, the total “yes” responses 
(i.e., indicating presence of symptom[s]) in both 
the ADIS-C and ADIS-P are added to obtain a 
total score. The total score is then compared 
against the GAD cut-off score. If GAD criteria are 
met, the child and guardian are asked if these 
symptoms in their entirety lead to significant 
interference and impairment in the child’s daily 
functioning. Impairment ratings are scored on 
a 9-point scale via a feeling thermometer. The 
feeling thermometer scores from the child and 
guardian are individually compared to the scores 
constituting a diagnosis as outlined in the manual. 
If both parties agree, a diagnosis of GAD is made, 
with the higher of the two scores being assigned 
to the child.  The ADIS-C/P demonstrates 
strong psychometric properties, constituting an 
acceptable assessment tool (Silverman, Saavedra, 
& Pina, 2001).
The YAM-5
The YAM-5 is an assessment measure intended 
for use with adolescents (Muris et al., 2017). 
This self-report questionnaire, administered 
by clinicians to the adolescent and guardian, 
assesses symptoms pertaining to all anxiety-
related disorders. This tool assesses the 
adolescent’s level and quantity of anxiety and 
worry, helping decipher which of the anxiety 
disorders is the most appropriate diagnosis. This 
measure is divided into two sections: part one, 
consisting of 28 items measuring the anxiety-
related disorders, including panic disorder and 
GAD; and part two, consisting of 22 items focusing 
on specific phobias. Regarding GAD, there are six 
specific items assessing associated symptoms. 
The YAM-5 demonstrates good psychometric 
properties, supporting its use in assessment 
(Simon, Bos, Verboon, & Muris, 2017). Additional 
benefits include its brief length, cost-effectiveness, 
and utility in situations where a typical diagnostic 
interview is not achievable.
The Severity Measure for GAD
The Severity Measure for GAD is a 10-item self-
report questionnaire intended for both C/As 
(Craske et al., 2013). This measure was developed 
for administration both upon a GAD diagnosis and 
throughout treatment. Interval lengths between 
each administration is dependent upon symptom 
severity and treatment status. It is advised that the 
Severity Measure for GAD is not the sole measure 
in assessing GAD symptom severity as it evaluates 
client’s’ thoughts, feelings, and behaviors during 
the week prior to assessment. As such, it should be 
used in addition to other tools throughout diagnosis 
and treatment. Questions on the Severity Measure 
investigate the C/A’s functioning in various areas of 
daily life, such as in the family, health, and school 
environment. Unlike other assessment tools 
developed for C/A onset GAD, the Severity Measure 
for GAD is not completed by a guardian. Clients rate 
themselves on a 5-point scale for each symptom 
listed. Investigation into this measure suggests 
good reliability and validity, supporting its use with 
clinical populations (Craske et al., 2013).
Adults
Unfortunately, limited research efforts focused 
toward GAD upon its introduction in the DSM-
III-R has impacted the quality of assessment 
approaches for adult populations. Concerning 
the current instruments used to assess anxiety, 
Spitzer et al. (2006) state, “measures of anxiety are 
seldom used in clinical practice because of their 
length, proprietary nature, lack of usefulness as a 
diagnostic and severity measure, and requirement 
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The Anxiety Disorders 
Interview Schedule for 
Children (ADIS-C/P)
The Youth Anxiety Measure for 
DSM-5 (YAM-5) The Severity Measure
Format Semi-structured interview Self-report questionnaire Self-report questionnaire
Method
Measures the presence 
and severity of anxiety and 
related symptoms and levels 
of distress and impairment 
such symptoms have on daily 
functioning
Assesses level and quantity 
of anxiousness and worry, 
helping decipher which of the 
anxiety disorders is the most 
appropriate diagnosis
Evaluates one’s thoughts, feel-
ings, and behaviors throughout 
the course of a week, including 
in the context of family, health, 
and school
Table 1: Summary of GAD assessment tools for children and adolescents.
of clinician administration rather than patient 
self-report” (p. 1092). Difficulty differentiating 
symptoms of GAD from other disorders is a second 
key barrier in assessment. Specifically, symptoms 
of anxiety disorders often overlap, making GAD 
commonly comorbid with other disorders (Rapee, 
1991). For instance, Eisenberg and colleagues 
(2007) report that 50.1% of individuals who 
screen positive for major depression also present 
GAD symptoms. The fourth edition of the GAD 
questionnaire (GAD-Q-IV; Newman et al., 2002), 
the Penn State Worry Questionnaire (PSWQ; 
Meyer, Miller, Metzger, & Borkovec, 1990), and 
the GAD-7 (Spitzer et al., Löwe, 2006) are three 
instruments that will be highlighted, while Table 2 
below provides a summary.
GAD-Q-IV
The GAD-Q-IV is founded on the GAD-Q, which 
was developed as an initial screening device to 
identify individuals with GAD. Though initially 
effective, the utility of the GAD-Q diminished as 
conceptualizations of GAD evolved (Newman et 
al., 2002). For instance, Newman et al. (2002) 
note that the GAD-Q defines pathological worry 
as unrealistic or excessive, regarding at least 
two life circumstances, and with the presence 
of at least 6 of 18 possible symptoms. These 
symptoms can include feelings of restlessness, 
irritability, and fatigue. The GAD-Q-IV, however, 
defines pathological worry as being excessive and 
uncontrollable, pertaining to a variety of life events 
or activities, and with the presence of at least 3 of 6 
symptoms considered as primary. Further, a critical 
difference between the GAD-Q and the GAD-Q-
IV is that while the GAD-Q requires symptoms to 
be “often present when anxious,” the GAD-Q-IV 
requires that clients experience the symptoms 
“more days than not” (Newman et al., 2002, p. 217). 
In terms of validity, Newman et al. (2002) report 
that the GAD-Q-IV is successful in differentiating 
GAD from other anxiety disorders, with 93% of 
clients with GAD producing a higher score on the 
scale than clients with different anxiety disorders. 
Overall, the GAD-Q-IV is considered an efficient 
and valid self-report measure for GAD that can 
be relied upon as an initial screening device. It is 
capable of decreasing the costs – whether time-
based, financial, or otherwise – that are associated 
with approaches characterized by a series of 
clinical interviews (Newman et al., 2002). 
PSWQ
The Penn State Worry Questionnaire (PSWQ; Meyer 
et al., 1990) is a 16-item self-report measure of 
the tendency to engage in worry. Participants rate 
themselves on a five-point Likert-type scale on 
items relating to experience with worry, such as type 
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Generalized Anxiety Disorder 
Questionnaire-IV (GADQ-IV)
Penn State Worry 
Questionnaire (PSWQ)
Generalized Anxiety 
Disorder 7-Item (GAD-7)
Format Self-report questionnaire Self-report questionnaire Self-report questionnaire
Method
Determines clients’ pathologi-
cal worry across a variety of life 
events/activities, with clients 
required to experience symptoms 
‘more days than not’
Assesses clients’ tendency 
to engage in worry, including 
their experiences with differ-
ent types of worry in different 
situations 
Identifies clients’ probable 
causes of GAD and the 
frequency to which such 
causes are experienced
Table 2: Summary of GAD assessment tools for adults.
of worry experienced in different situations. The 
PSWQ demonstrates strong internal consistency 
and high test-retest reliability (Brown, Antony, & 
Barlow, 1992; Meyer et al., 1990). The PSWQ has 
good criterion and construct validity, making it a 
valid measure of trait anxiety (Brown et al., 1992; 
Meyer et al., 1990). Additionally, the PSWQ has 
high convergent and discriminant validity, further 
supporting its use (Brown et al., 1992).
GAD-7
The GAD-7 (Spitzer et al., 2006) is a brief, 7-item 
self-report anxiety scale designed to identify 
probable cases of GAD. Participants use a four-
point Likert-type scale to report the frequency 
with which they experience the following 
characteristics: anxiousness, inability to control 
worry, excessive worry about multiple things, 
trouble relaxing, severe restlessness, irritability, 
and fear of awful things happening. The GAD-7 
has excellent internal consistency and good test-
retest reliability (Spitzer et al., 2006). It also has 
good procedural validity and construct validity, 
as demonstrated by strong positive associations 
with multiple domains of functional impairment. 
Convergent validity was determined by comparing 
correlations of the GAD scale with both the Beck 
Anxiety Inventory (BAI) and the anxiety subscale 
of the Symptom Checklist-90. Collectively, the 
strengths of the GAD-7 lie in its ability to efficiently 
assess GAD symptoms across diverse clinical 
settings, while also differentiating any overlap 
between anxiety and depression. In addition, the 
administration of the GAD-7 does not require a 
clinician – a factor to which Spitzer and colleagues 
(2006) conclude can provide significant service to 
those working in busy health settings.
Treatment
Children and Adolescents
Though several treatment options are available 
for C/As diagnosed with GAD, such interventions 
vary in empirical support (Cheng & Myers, 2011). 
Oftentimes, treatment is a combination of the 
several methods. It is cautioned that several 
treatment routes may be implemented prior to 
discovering what is most effective and efficient 
for each individual client. Guidelines for treatment 
include the following: complete and thorough 
clinical assessment prior to diagnosis and treatment 
implementation, consideration of potential/existing 
comorbid disorders, and to prioritize targeted 
symptoms and treatment goals (Cheng & Myers, 
2011). Furthermore, family preference, availability 
of treatment options, economic cost, and duration, 
need to be considered in treatment development. 
The most frequently used and strongly supported 
treatment options for C/As highlighted in this paper 
include cognitive behavioral therapy (CBT) and 
psychopharmacologic interventions.
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CBT
CBT is a popular intervention tool for C/A-onset 
GAD (Wehry, Beesdo- Baum, Hennelly, Sucheta, 
Connolly, & Strawn, 2015). CBT consists of six 
fundamental characteristics: psychoeducation, 
creating management strategies for physical 
symptoms, cognitive restructuring, developing 
problem-solving strategies, implementing 
systematic exposure, and planning for 
relapse (Velting, Setzer, & Albano, 2004). The 
psychoeducation component involves identifying 
and addressing misconceptions, as well as 
educating the C/A and guardian about the nature 
of anxiety, how to differentiate normal levels of 
worry and anxiety from abnormal levels, and the 
effects of excessive worry and anxiety. 
According to Velting et al. (2004), techniques 
taught to manage physical reactions may include 
relaxation training or diaphragmatic breathing 
exercises. The clinician attempts to educate the 
client about the connection between physiological 
and emotional arousal and anxiety. Cognitive 
restructuring involves identifying and challenging 
specific anxiety-provoking thoughts and images, 
lessening their degree of presence and effects. 
Developing problem-solving strategies includes 
creating and practicing tools for the C/A for coping 
with uncertain events or expected challenges in 
daily life. Practicing systematic exposure with 
clients involves exposing clients to their unique 
feared situation or stimuli, which may include 
imagination, stimulation, and in vivo methods (i.e., 
flooding –  involving rapid exposure to the feared 
stimuli, versus systematic desensitization – 
involving gradual exposure). The goal of systemic 
exposure is to desensitize the individual to their 
fears. Lastly, relapse prevention planning involves 
creating strategies for addressing relapse in 
advance. 
It is recommended that CBT takes into account 
clients’ developmental level, potential and/or 
present comorbid disorders, and level of guardian 
involvement in maintaining GAD (Cheng & Myers, 
2011). Empirical research provides support for 
CBTs use with C/A populations (Piacentini et 
al., 2013). Piacentini et al. (2013) found that 
when participants with various anxiety disorders 
(e.g., separation, generalized, and social) were 
randomly assigned to either three months of CBT, 
sertraline (SRT), a combination of both, or placebo, 
participants treated with CBT showed a significant 
reduction in symptoms. This efficacy remained 
even at 36 weeks post-treatment for >80% of 
participants. However, evidence suggests that a 
combination approach, utilizing both CBT and SRT, 
is more efficacious than an independent approach 
(Piacentini et al., 2013; Walkup et al., 2013). 
Although traditional CBT involves a face-to-
face therapeutic alliance, online-based CBT 
interventions are also rising in popularity (Spence 
et al., 2008). Online CBT can help address issues 
of stigma attached to seeking mental health 
attention, poor access to services, and financial 
issues for C/As requiring intervention (Spence et 
al., 2008). For instance, BRAVE-ONLINE is a form 
of CBT treatment delivered entirely online (Spence 
et al., 2008). BRAVE-ONLINE aims to be a more 
accessible and practical mode of intervention. 
The program consists of 10 weekly C/A sessions, 
with each session approximately 60 minutes long. 
Following the 10 initial sessions, two booster 
sessions are administered at the one month 
and three month mark. Within the program are 
sessions specifically for the guardian to complete, 
aimed at anxiety psychoeducation. Various anxiety 
management strategies are also included in the 
program, including: understanding and recognizing 
physiological and emotional symptoms of anxiety; 
relaxation strategies; cognitive strategies, such 
as positive self-talk and cognitive restructuring; 
graded exposure to specific fears; and self-
reinforcement of brave behavior. Finally, weekly 
homework assignments help further understanding 
of the strategies taught and provide practice 
opportunities. Clients’ interactions with their 
internet therapist are limited to an initial telephone 
Spectrum  |  InterdIScIplInary undergraduate reSearch 8
doi: 
PUBLISHED:Published:
10.29173/spectrum24
October, 2018
Cognitive Behavioral Therapy (CBT) Psychopharmacological Interventions
Method
Client learns about the nature of his/
her anxiety while building strategies for 
managing physical symptoms, prob-
lem-solving skills, and worry tolerance, 
while also identifying and challenging 
anxiety-provoking thoughts /images
Selective Serotonin Reuptake Inhibitors (SS-
RIs), an oral medication, block the reabsorp-
tion of serotonin in the brain, facilitating the 
creation of extra serotonin
Administration Face-to-face or online (e.g., BRAVE-ON-LINE) E.g., Fluoxetine
Effectiveness
Significant reduction in symptoms last-
ing 36 weeks post-treatment for >80% 
of participants
(Piacentini et al., 2013)
Reduces anxiety in 40-50% of clients (Cheng & 
Myers, 2011)
Table 3: Summary of GAD treatment options for children and adolescents.
call to summarize the treatment plan, a mid-
program telephone call, and brief weekly emails 
in which the therapist provides feedback about 
performance.  
However, while results suggest online-based 
treatments reduce anxiety levels and GAD 
symptoms (Spence et al., 2008), research also 
demonstrates that these effects are more 
substantial if the online therapy is combined with 
regular in-person interactions with a therapist 
(Spek et al., 2007). Additional empirical support 
is needed before adopting online treatment as 
the standard intervention strategy. Further, while 
online-based CBT may be a beneficial alternative 
that is time and cost effective, there remains 
a lack of opportunity to build rapport and a 
strong therapeutic alliance (Spek et al., 2007). 
Although online programs attempt to maintain the 
therapeutic alliance with an assigned therapist, 
additional research is needed to determine if 
these attempts are successful.
Psychopharmacologic Interventions
Although popular, psychopharmacologic 
treatments (e.g., Selective Serotonin Reuptake 
Inhibitors [SSRIs]) are not highly effective in 
reducing GAD symptom severity in C/As when used 
as the only treatment method (Cheng & Myers, 
2011). Research demonstrates that monotherapy 
with SSRIs is only effective in reducing anxiety 
in 40-50% of clients (Cheng & Myers, 2011). 
Alternatively, psychopharmacologic treatment is 
commonly paired with CBT-oriented interventions 
in treating C/A-onset GAD (Wehry et al., 2015). This 
likely results from empirical support of combining 
psychopharmacologic approaches with CBT in 
adult populations (Wehry et al., 2015). Support 
for such multimodal treatment plans in C/As are 
evident in longitudinal analyses, in which 80% of 
clients maintain positive response rates at 24 and 
36-week follow-ups (Piacentini et al., 2013). It is 
suggested that a combination of treatments is 
both durable and sustainable, with remission rates 
impressively low (Ginsburg et al., 2014).
Although research supports the inclusion of SSRIs 
in treatment planning, clinicians are advised to 
consider potential side effects and to perform a 
cost-benefit analysis prior to administering any 
medication. Fluoxetine, a common and successful 
SSRI used in treating C/As with GAD, has various 
potential adverse side effects including nausea, 
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abdominal pain, drowsiness, and headaches 
(Beidel et al., 2007). While the use of such 
medications is superior in efficacy compared 
to placebos, it is important to consider these 
potential side effects in treatment planning 
(Beidel et al., 2007).
Adults
There are various treatment options available 
for adult-onset GAD, such as applied relaxation 
(AR), non-directive supportive therapy, and 
psychoanalytic therapy (Hupport & Sanderson, 
2010). AR was developed in the 1970s and 
conceptualizes anxiety as interacting with 
cognitive, physiological, affective, and behavioral 
systems. AR provides clients with coping skills 
that prevent their physiological reactions to 
anxiety from initiating the other systems, therein 
stopping the cycle of anxiety (Hayes-Skelton & 
Roemer, 2013). Non-directive supportive therapy; 
however, provides clients with an open atmosphere 
to share and discuss their feelings (Brenes et al., 
2015). Similarly, psychoanalytic therapy is based 
on the idea that unconscious conflicts contribute 
to or cause ailments (Milton, Polmear, & Fabricius, 
2011). Psychoanalytic therapy helps clients by 
using techniques such as free association, in 
which clients say whatever is on their mind (Milton 
et al., 2011). In addition to AR, non-directive 
supportive therapy, and psychoanalytic therapy, 
traditional CBT and Acceptance and Commitment 
Therapy (ACT) have widespread empirical support 
for their effectiveness in treating GAD (Gould, Otto, 
Pollack, & Yap, 1997; Hupport & Sanderson, 2010; 
Roemer & Orsillo, 2007; Wetherell et al., 2011).
CBT
While CBT, a scientifically-based form of 
psychotherapy, is effective in treating numerous 
disorders, it has received the most support for 
alleviating worry and anxiety (Huppert & Sanders, 
2010). CBT is labelled as an “empirically supported 
treatment” by the Task Force of the Division of 
Clinical Psychology of the American Psychological 
Association (Huppert & Sanders, 2010). It is distinct 
in its brief nature, with a tendency to focus on the 
present and a problem-solving-like approach. 
Based on the cognitive model, CBT examines the 
way clients may perceive a situation and identifies 
the dynamic between such perceptions and their 
emotions (Beck Institute for Cognitive Behavior 
Therapy, 2016). A typical CBT intervention for GAD 
includes cognitive restructuring, relaxation training, 
anxiety management training, situational and 
imaginal exposure, and systematic desensitization. 
These techniques may be applied independently or 
in combination with each other and other treatments 
(Gould et al., 1997). Anxiety management training 
is an especially key CBT technique that clinicians 
may use with clients suffering from GAD. Anxiety 
management training involves helping clients 
focus on their fears of being unable to cope with 
their excessive and uncontrollable worry (Gould 
et al., 1997). In addition to combining relaxation 
and self-talk, this technique utilizes an “image 
switching” procedure, in which clients are exposed 
to an anxiety-evoking image only to then adapt 
a more reassuring image (Gould et al., 1997). In 
their meta-analysis, Gould and colleagues (1997) 
report that the average client with GAD needs 
9.5 sessions of CBT, with among 30% to 66% of 
clients experiencing improvements in anxiety. This 
finding aligns with Huppert and Sanderson’s (2010) 
conclusion that approximately 50% of all clients 
are considered to be responders to CBT.
ACT
While CBT uses a problem-solving approach, ACT 
focuses on acceptance. Specifically, acceptance is 
a process in which clients’ psychological flexibility 
is enhanced to counter experimental avoidance 
and ineffective coping styles (Luoma, Haynes, and 
Walser, 2007). Thus, while clinicians approaching 
treatment for GAD via CBT will attempt to reduce 
problematic thoughts by investigating their nature 
and associated consequences, an ACT approach 
would encourage clients to acknowledge the 
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Cognitive Behavioral Therapy (CBT) Acceptance and Commitment Therapy (ACT)
Method
Client learns about the nature of his/her 
anxiety while building strategies for man-
aging physical symptoms, problem-solving 
skills, and worry tolerance, while also iden-
tifying and challenging anxiety-provoking 
thoughts /images
Utilizes the process of acceptance, in 
which clients’ psychological flexibility is 
enhanced to counter experiential avoid-
ance and ineffective coping styles, while 
maximizing engagement in meaningful 
daily activities
Administration Face-to-face or online Face-to-face
Effectiveness
Up to 66% of clients experience improve-
ments in anxiety after 9.5 sessions of CBT 
(Gould et al., 1997)
Approximately 50% of clients report sig-
nificantly improved quality of life (Roemer 
and Orsillo, 2007)
Table 4: Summary of GAD treatment options for adults.
presence of such problematic cognitions and 
respond appropriately. With ACT, the goal is 
to increase clients’ engagement in meaningful 
activities across various domains of everyday 
life (Wetherell et al., 2011). In a study by Roemer 
and Orsillo (2007) investigating the effectiveness 
of acceptance-based approaches, participants 
demonstrated significant improvements in GAD, 
worry, and anxiety. These improvements were 
maintained upon a 3-month follow-up assessment, 
with participants reporting significantly improved 
quality of life. Interestingly, at approximately 
50%, Roemer and Orsillo (2007) estimate that 
ACT has the same treatment-response rate as 
CBT for GAD populations. Lastly, Wetherell and 
colleagues (2011) note that ACT is relatively easy 
for clinicians to learn – adding to the potential 
for ACT being used to treat GAD across various 
mental health settings.
Conclusion
Despite its increasing prevalence, the GAD 
research area is generally premature. This 
is evident by a lack of empirically supported 
assessment measures, intervention strategies, 
and treatment options. Historically, anxiety 
scales have had limited presence in clinical 
settings due to issues of length, clinician-required 
administration, and difficulty differentiating 
between anxiety and comorbid conditions. 
Regarding treatment, traditional CBT remains the 
standard approach to GAD due to its empirical 
support as an effective intervention in C/A and 
adult populations. While there is strong support 
for the use of CBT and psychopharmacologic 
interventions in C/A populations, clinicians’ 
options beyond these routes are limited. Increasing 
popularity of online CBT programs, however, 
offers a positive resolution to accessibility issues. 
Overall, the C/A population remains untended in 
comparison to adult populations, to which more 
efficient assessment methods are available, 
and new treatment approaches are continuously 
being modified – such as combining CBT and 
ACT. Nonetheless, there are certain barriers to 
successful and available treatment across the 
collective age-spectrum – including cost, time, and 
accessibility.
With mental disorders such as GAD being among 
the most significant threats to public health, it is 
critical that successful prevention and intervention 
measures are easily accessible. If more is 
understood in terms of etiological factors and 
course, then prevention and treatment methods 
can improve. Therefore, while the availability of 
new assessment and treatment models are a 
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concern, further investigations into the onset of 
GAD and preventive measures remain essential 
moving forward.
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